3,4-dimethoxybenzoic acid, min. 99%, for synthesis, 250 g, plastic packaging.

6-(2-(Methylsulfonyl)pyrimidin-5-yl)-N-(prop-2-yn-1-yl)hex-5-ynamide, 98.0%, 250mg

ROTI®Cell DPBS, 1 l

Hydroxypivalic acid, 98.0%, 500g

2-Fluoro-3-formylpyridine, 95.0%, 5g

(3-Chloro-2-fluoro-5-(trifluoromethyl)phenyl)boronic acid, 97.0%, 5g

3-Methyl-1-butanol>99.0%(GC)500mL

4-PHENOXYANILINE, 95.0%, 25g

N-[4-(Hydroxymethyl)phenyl]acetamide>98.0%(GC)5g

2-Methyl-2H-benzo[b][1,4]oxazin-3(4H)-one, 95.0%, 10g

Gadolinium(III) chloride hexahydrate, 95.0%, 25g

2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95+%, 250mg

1,4-DIAZEPAN-6-ONE 2HCL, 95.0%, 1g